Effects of recombinant human growth hormone (rhGH) administration on body composition and cardiovascular risk factors in obese adolescent girls

Conclusions: Administering rhGH in small doses is able to stabilize IGF-1 levels in obesity. We have also shown that rhGH administration leads to an improvement in some markers of cardiovacular risk with without adversely affecting glucose tolerance.Trial registration: Clinical Trial Registration Number: NCT01169103.
Source: International Journal of Pediatric Endocrinology - Category: Endocrinology Authors: Source Type: research